WASHINGTON, May 12 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of a drug designed for the treatment of restless legs syndrome.
WASHINGTON, Sept. 5 (UPI) -- The U.S. Food and Drug Administration announced approval Wednesday of the first generic versions of the blood pressure and heart medication Coreg.
WASHINGTON, July 2 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Lamisil (terbinafine hydrochloride) tablets to treat nail fungus infection.
WASHINGTON, April 24 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Ambien (zolpidem tartrate) for the treatment of insomnia.
WOODCLIFF LAKE, N.J., April 9 (UPI) -- U.S. generic drug maker Barr Pharmaceuticals said Modnay its patent covering its extended-cycle oral contraceptive, Seasonale will reissue.
CORONA, Calif., Feb. 12 (UPI) -- GlaxoSmithKline has agreed to pay Watson $35 million to settle a U.S. patent infringement lawsuit involving Wellbutrin XL.
BRISTOL, Tenn., Dec. 27 (UPI) -- U.S. firm Watson Pharmaceuticals has acquired the U.S. rights to Stellar Pharmaceuticals' Uracyst to treat interstitial cystitis.
CHICAGO, July 17 (UPI) -- Takeda Pharmaceuticals North America Inc. is launching a nearly $100 million ad campaign for a sleeping pill that is not a controlled substance.
CORONA, Calif., May 9 (UPI) -- Watson Pharmaceuticals said Tuesday it has tentative approval to market a generic of Duramed contraceptive Seasonale.
CORONA, Calif., March 13 (UPI) -- California's Watson Pharmaceuticals Inc. said Monday it was paying about $1.9 billion for generic drug maker Andrx Corp.
